SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Diluted Shares Outstanding (Weighted Average)
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Diluted Shares Outstanding (Weighted Average) of 1.02 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.02M shares, a 801.49% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 5.03M shares, a 1151.77% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 2.77M shares, a 1287.34% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 2.23M shares, a 2251.11% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 1.64M shares, a 1318.20% increase from fiscal 2024.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 115.49K shares, a 93.81% decline from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 1.87M shares, a 39.51% increase from fiscal 2022.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 1.34M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.02M shares 10-Q · filed 2026-09-24 | 760.58K shares 10-Q · filed 2026-09-24 | 2.94M shares derived: average of 3 quarters · filed 2026-09-24 | 2.76M shares derived: average of 4 quarters · filed 2026-09-24 | ||||
| 2026-03-31 | 5.03M shares 10-Q · filed 2026-05-15 | 3.90M shares derived: average of 2 quarters · filed 2026-05-15 | 3.35M shares derived: average of 3 quarters · filed 2026-05-15 | 2.54M shares derived: average of 4 quarters · filed 2026-09-24 | ||||
| 2025-12-31 | 2.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 2.50M shares derived: average of 2 quarters · filed 2026-03-31 | 1.71M shares derived: average of 3 quarters · filed 2026-09-24 | 1.64M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 2.23M shares 10-Q · filed 2025-11-13 | 1.17M shares derived: average of 2 quarters · filed 2026-09-24 | 1.26M shares 10-Q · filed 2025-11-13 | 736.97K shares derived: average of 4 quarters · filed 2026-09-24 | ||||
| 2025-06-30 | 112.61K shares 10-Q · filed 2026-09-24 | 1.13M shares 10-Q · filed 2025-08-13 | 76.61K shares 10-Q · filed 2026-09-24 | 766.02K shares 10-Q · filed 2025-08-13 | 238.07K shares derived: average of 3 quarters · filed 2026-09-24 | 202.31K shares derived: average of 4 quarters · filed 2026-09-24 | ||
| 2025-03-31 | 401.96K shares 10-Q · filed 2026-05-15 | 10.05M shares 10-Q · filed 2025-05-08 | 300.81K shares derived: average of 2 quarters · filed 2026-05-15 | 232.21K shares derived: average of 3 quarters · filed 2026-05-15 | 195.20K shares derived: average of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | 199.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 147.33K shares derived: average of 2 quarters · filed 2026-03-31 | 126.29K shares derived: average of 3 quarters · filed 2026-03-31 | 115.49K shares 10-K · filed 2026-03-31 | 2.89M shares 10-K · filed 2025-02-26 | |||
| 2024-09-30 | 95.00K shares 10-Q · filed 2025-11-13 | 2.38M shares 10-Q · filed 2024-11-13 | 89.60K shares derived: average of 2 quarters · filed 2025-11-13 | 87.44K shares 10-Q · filed 2025-11-13 | 2.19M shares 10-Q · filed 2024-11-13 | 1.07M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 84.20K shares 10-Q · filed 2025-08-13 | 2.10M shares 10-Q · filed 2024-09-04 | 83.64K shares 10-Q · filed 2025-08-13 | 2.09M shares 10-Q · filed 2024-09-04 | 1.39M shares derived: average of 3 quarters · filed 2025-08-13 | 1.53M shares derived: average of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | 2.08M shares 10-Q · filed 2025-05-08 | 16.57M shares 10-Q · filed 2024-05-13 | 2.04M shares derived: average of 2 quarters · filed 2025-05-08 | 2.02M shares derived: average of 3 quarters · filed 2025-05-08 | 1.96M shares derived: average of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | 2.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 1.99M shares derived: average of 2 quarters · filed 2025-02-26 | 1.92M shares derived: average of 3 quarters · filed 2025-02-26 | 1.87M shares 10-K · filed 2025-02-26 | 14.92M shares 10-K · filed 2024-03-21 | |||
| 2023-09-30 | 1.97M shares 10-Q · filed 2024-11-13 | 1.88M shares derived: average of 2 quarters · filed 2024-11-13 | 1.82M shares 10-Q · filed 2024-11-13 | |||||
| 2023-06-30 | 1.78M shares 10-Q · filed 2024-09-04 | 14.26M shares 10-Q · filed 2023-08-14 | 1.74M shares 10-Q · filed 2024-09-04 | 13.95M shares 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | 1.70M shares 10-Q/A · filed 2024-09-04 | 13.64M shares 10-Q · filed 2024-05-13 | ||||||
| 2022-12-31 | 1.34M shares 10-K/A · filed 2024-09-04 | 10.35M shares 10-K · filed 2024-03-21 | ||||||
| 2022-06-30 | 9.31M shares 10-Q · filed 2023-08-14 | 9.29M shares 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |